Pacific Biosciences (NASDAQ:PACB) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Pacific Biosciences beat estimated earnings by 3.57%, reporting an EPS of $-0.27 versus an estimate of $-0.28.
Revenue was up $31.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 13.08% drop in the share price the next day.
Here’s a look at Pacific Biosciences’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.32 | -0.32 | -0.33 | -0.36 |
| EPS Actual | -0.27 | -0.26 | -0.31 | -0.35 |
| Revenue Estimate | 48.76M | 40.30M | 34.38M | 26.24M |
| Revenue Actual | 55.69M | 47.57M | 38.90M | 27.35M |
To track all earnings releases for Pacific Biosciences visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
